Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • TALi Digital’s (TD1) partnership with Times Group of India has gone live to the Indian consumer market ahead of schedule
  • The advertising and communication plan with the largest media conglomerate in India will highlight the benefit of TALi’s cognitive performance tools to the health and education of children between the ages of three and eight
  • The direct-to-consumer versions of TALi Detect and TALi Train are now approved and available on the Google Play store in India
  • The initial digital campaign with the Times Group has launched, with print and radio to roll out later in this month
  • TALi Digital shares are down 7.14 per cent, trading at 5.2 cents

TALi Digital’s (TD1) partnership with Times Group of India has gone live to the Indian consumer market ahead of schedule.

TALi Digital is a digital health business, targeting attention in children with game-based programs. The technology combines more than 25 years of research in developmental psychology and cognitive neuroscience to deliver easy-to-use, game-based digital programs to assess and strengthen attention early in life.

The Times Group is the largest media conglomerate in India, engaging with over 550 million people every month via print, TV, radio and online.

The advertising and communication plan will highlight the benefit of TALi’s cognitive performance tools to the health and education of children between the ages of three and eight.

The direct-to-consumer versions of TALi Detect and TALi Train are now approved and available on the Google Play store in India.

Over 95 per cent of all Indian consumers have an Android device and access the Google Play store. TALi will receive 100 per cent of the revenue from any downloads of the TALi product in the Indian market.

“We are pleased with the progress we have made so far in the Indian market, one of our key strategic growth regions, as we look to commercialise our technology internationally,” said Managing Director Glenn Smith.

“The approval of the direct-to-consumer versions of TALi DETECT and TALi TRAIN on the Google Play store was the first important milestone in this market, where more than 95 per cent of Indian consumers use Google-based devices.”

The company says the Indian market represents a significant growth opportunity for TALi Digital, as approximately one in eight children between the ages of two and nine are estimated to have at least one neurodevelopmental disorder, representing a direct opportunity of 30 million children in the TALi age range.

The initial digital campaign with the Times Group has launched, with print and radio to roll out later this month. Due to the large scale of the Indian market, the launch program will be staggered over months via channel and region to build brand awareness, recognition and trust in the early childhood family segment.

The company says shareholders can expect that any revenue generation from India may follow a similar pattern over the forward periods.

TALi Digital shares are down 7.14 per cent, trading at 5.2 cents at 1:15 pm AEST.

TD1 by the numbers
More From The Market Herald
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) signs COVID-19 test manufacturing contract

AnteoTech (ADO) has finalised and signed a contract manufacturing agreement with Spanish manufacturer, Operon.
Botanix Pharmaceuticals (ASX:BOT) - President & Executive Chairman, Vince Ippolito - The Market Herald

" Botanix Pharmaceuticals (ASX:BOT) receives encouraging results from canine study

Botanix Pharmaceuticals (BOT) says it has received encouraging results from a small pilot study of its synthetic CBD treatment in canines with atopic
Healthia (ASX:HLA) to purchase The Eyecare Place

" Healthia (ASX:HLA) to purchase The Eyecare Place

Healthia (HLA) has entered into agreements to purchase The Eyecare Place, an optical store located in Abbotsford, Victoria.
Avita Therapeutics (ASX:AVH) - CEO, Dr Michael Perry - The Market Herald

" Avita Medical (ASX:AVH) reports solid revenue growth over March quarter

Avita Medical (AVH) reported a 126-per-cent revenue increase and steady growth in procedural volumes in its review of the March quarter.